Skip to Content

Anidulafungin Teva 100 mg Powder for Concentrate for Solution for Infusion

Shortage
Licence status
Authorised: 16/02/2018
Active substances
Anidulafungin
Dosage Form
Powder for concentrate for solution for infusion
Licence number
PA1986/045/001
Licence holder
Teva B.V.

Licence information

ATC code
J02AX Other antimycotics for systemic use, J02AX06 anidulafungin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/02/2018